Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

Maio, M.; Grob, J.-J.; Aamdal, S.; Bondarenko, I.; Robert, C.; Thomas, L.; Garbe, C.; Chiarion-Sileni, V.; Testori, A.; Chen, T.-T.; Tschaika, M.; Wolchok, J. D.

期刊名称Journal of Clinical Oncology
作者Maio, M.; Grob, J.-J.; Aamdal, S.; Bondarenko, I.; Robert, C.; Thomas, L.; Garbe, C.; Chiarion-Sileni, V.; Testori, A.; Chen, T.-T.; Tschaika, M.; Wolchok, J. D.
卷第33卷
期第10期
印刷ISSN0732-183X
电子ISSN1527-7755
文件大小122.22KB
发表时间2015-04-01
DOI10.1200/JCO.2014.56.6018
页码1191-1196

发现好书期刊，享受阅读乐趣

Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial